Introduction {#Sec1}
============

Prostate cancer (PCa) is common among men in developed countries, however, little is known about modifiable risk factors \[[@CR1]\]. Investigating potential risk factors for prostate cancer is challenging because incidence rates are affected by PCa screening. Thus, to avoid potential detection bias, epidemiologic analyses often limit evaluations of prostate cancer to clinically relevant subtypes \[[@CR2]\].

Previous epidemiologic studies have linked farming to an increased risk of prostate cancer \[[@CR3]--[@CR9]\]. Analyses of data from the Agricultural Health Study (AHS) revealed a significant excess of both PCa incidence \[[@CR10]\] and mortality \[[@CR11]\] among pesticide applicators compared to the general population. Exposure to specific individual organochlorine (OC) and organophosphate (OP) insecticides have been linked to prostate cancer in multiple studies \[[@CR12]--[@CR16]\]. Specifically, a previous evaluation in the AHS reported increased risks of aggressive PCa with exposure to aldrin (OC) as well as the organodithioate class of OP insecticides, including fonofos (OP), terbufos (OP), and malathion (OP) \[[@CR12]\]. Other studies reported associations between increased risks of prostate cancer and chlordecone (OC) \[[@CR15], [@CR16]\] as well as serum metabolite concentrations of chlordane (OC) \[[@CR13]\], hexachlorocyclohexanes (OC) \[[@CR14]\], and DDT (OC) \[[@CR14], [@CR16]\].

We previously published analyses on exposure to 50 commonly reported pesticides used at and before study enrollment and risk of aggressive PCa in the AHS \[[@CR12]\]. In the current paper, we use data from the AHS to evaluate possible associations between aggressive PCa and the use of 39 additional pesticides not previously considered by adding 13 years of follow-up time and 811 additional aggressive PCa cases.

Methods {#Sec2}
=======

Study population and case ascertainment {#Sec3}
---------------------------------------

The AHS is an ongoing prospective cohort that includes 52,934 licensed private pesticide applicators in Iowa and North Carolina and 4916 licensed commercial applicators in Iowa. The cohort has been described in detail previously \[[@CR17]\]. Briefly, the cohort is composed of individuals (82% of the target population enrolled) seeking licenses for pesticides which the U.S. Environmental Protection Agency (EPA) designated restricted use. In the AHS, pesticide exposure information has been collected in 3 phases of questionnaires\--Phase 1 (1993--1997), Phase 2 (1999--2003), and Phase 3 (2005--2010),---with each phase including self-administered questionnaires or a computer assisted telephone interview (CATI) covering demographic, lifestyle, and occupational characteristics. In Phase 1, a total of 57,310 applicators completed the enrollment questionnaire and 25,291 returned the 'Take-Home Applicator' questionnaire. Of those initially enrolled, 36,341 applicators completed the Phase 2 'Pesticide Use Module Applicator' questionnaire, and 24,170 applicators returned the Phase 3 questionnaire (Fig. [1](#Fig1){ref-type="fig"}). Full text of all questionnaires is available at <https://aghealth.nih.gov/collaboration/questionnaires.html>. Fig. 1Timeline of study phases, questionnaires, and follow-up for the Agricultural Health Study (AHS) along with analytic populations for the current study

We regularly linked cohort members to state mortality registries and the National Death Index to determine vital status. We also regularly linked participants to cancer registries in Iowa (cases reported through 2015) and North Carolina (cases reported through 2014) to determine incident cancers. Cancers were classified according to the International Classification of Diseases for Oncology, third revision (ICD-O-3) \[[@CR18]\]. Aggressive prostate cancer was defined as having one or more of the following tumor characteristics: distant stage, poorly differentiated grade, Gleason score ≥ 7, or fatal prostate cancer (i.e. underlying cause of death was prostate cancer).

The study protocol, including implied informed consent for completion of questionnaires, was approved by all relevant institutional review boards.

Exposure assessment {#Sec4}
-------------------

We previously published an analysis of 50 pesticides first reported on the Phase 1 enrollment questionnaire \[[@CR12]\]. For the current analysis, we focused on those pesticides that were first reported at take-home (Phase 1 take-home questionnaire) or follow-up (Phase 2 and Phase 3 questionnaires), but not included in prior analyses (*n* = 39 pesticides). We only evaluated pesticides with 15 or more exposed aggressive PCa cases. Questions regarding pesticide use differed by questionnaire (Fig. [1](#Fig1){ref-type="fig"}). The take-home questionnaire provided a checklist of specific pesticide names/active ingredients and applicators marked those that they had ever used. The follow-up questionnaires included open-ended questions and applicators provided the name of the pesticide(s) used. In the Phase 2 questionnaire, applicators reported on use for the last year that they farmed. In the Phase 3 questionnaire, applicators were asked about use since their last questionnaire or interview (which could have been at Phase 1 enrollment, Phase 1 take-home, or Phase 2). The Phase 3 questionnaire also asked applicators to report the lifetime duration (in years) of use for each of the reported pesticides. Since the take-home and follow-up questionnaires were structured differently, this resulted in two different analytic groups: ever/never use to pesticides first reported at take-home (20 pesticides) and ever/never use to pesticides first reported at follow-up (19 pesticides). For pesticides first reported at follow-up (19 pesticides), we also evaluated lifetime duration of use (years), which was ascertained on the Phase 3 questionnaire.

Because many of these pesticides have never been evaluated in the AHS, we also assessed the plausibility of users' duration information (excluding arsenical pesticides). We began by calculating the maximum number of years a pesticide could have been used. This was calculated by subtracting the year a pesticide/active ingredient was first registered in the U.S. from the year the individual completed the phase 3 questionnaire (2005--2010; the year participants responded to questions about duration of use for the given pesticides in the AHS). We used four different sources of information to determine registration year, including the chemical specific Registration Eligibility Decision (RED) published by the U.S. EPA, the EPA's document on "Chemicals Registered for the First Time as Pesticidal Active Ingredients Under FIFRA" \[[@CR19]\], different versions of the Farm Chemicals Handbooks \[[@CR20]\] covering the timespan of the AHS, and the EXTOXNET: the Extension Toxicology Network \[[@CR21]\], which is a Pesticide Information Project of Cooperative Extension Offices of Cornell University, Michigan State University, Oregon State University, and the University of California at Davis. We also evaluated whether any pesticide had been canceled prior to 2010 using the EPA's chemical specific REDs, U.S. Federal Register notices, as well as the Sittig's Handbook of Pesticides and Agricultural Chemicals \[[@CR22]\]. We found that fluazifop-butyl and disulfoton had been canceled in the latter halves of 2004 \[[@CR23]\] and 2009 \[[@CR24]\], respectively. To assess plausibility of duration responses by AHS applicators, we compared the maximum number of years a pesticide could have been available for purchase to self-reported life years of use. We evaluated the frequency and proportion of applicators using a given pesticide as well as the number and proportion of users with reported years of use that were plausible.

Analytic population {#Sec5}
-------------------

All respondents completed the enrollment questionnaire; however, responses about pesticide use from the take-home and follow-up questionnaires were structured differently resulting in two different analytic groups (Fig. [1](#Fig1){ref-type="fig"}). The first analytic group included participants that responded to the take-home questionnaire. Among the 25,291 total participants who completed the take-home questionnaire, we excluded 4368 individuals (2375 commercial applicators \[did not receive the Phase 3 follow-up questionnaire\], 556 women, 80 who had moved out of state, 620 with prevalent cancer or those diagnosed before completing the questionnaire, and 737 who were diagnosed with non-aggressive PCa during follow-up), leaving 20,923 private applicators (20,040 non-cases/883 aggressive PCa cases) for analysis. This analytic set was used to evaluate: (1) ever/never use as indicated on the take-home questionnaire, and (2) ever/never use considering take-home questionnaire use plus information reported at one or both follow-up questionnaire(s) (Phase 2 and/or 3). The second analytic group included participants that responded to both follow-up questionnaires (Phase 2 and Phase 3). Among the 21,142 participants that completed both follow-up questionnaires (Phase 2 and Phase 3), we excluded 2209 individuals (640 women, 70 who had moved out of state, 963 individuals with prevalent cancer or those diagnosed before completing the Phase 2 or Phase 3 questionnaire, and 536 who were diagnosed with non-aggressive PCa during follow-up), leaving 18,933 individuals (18,199 non-cases/734 aggressive PCa cases) for analysis.

Statistical analyses {#Sec6}
--------------------

We used Cox proportional hazards models, with age as the time scale, to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between individual pesticide use and aggressive PCa risk. We censored follow-up at the time of aggressive prostate cancer diagnosis, death, movement out of the state, or at December 31, 2014 for North Carolina and 2015 for Iowa, whichever came first. Supplemental Tables [1](#MOESM1){ref-type="media"} and [2](#MOESM2){ref-type="media"} report associations for overall PCa risk. We adjusted all models for year of birth; state (North Carolina, Iowa); family history of prostate cancer in first-degree relatives; race; and cigarette smoking status (never, former, current, missing) based on information on the Phase 1 enrollment questionnaire. Other covariates, including body mass index (BMI: underweight, normal, overweight, obese), fruit servings (\< 1/day, ≥ 1/day), and leisure-time physical activity in the winter (none, \> 0--2 h/week, ≥ 3 h/week), did not materially impact observed point estimates (≥ 10%) and, therefore, were not retained in models. We evaluated correlations between ever/never exposure to individual pesticides using the Pearson correlation coefficient and conducted additional adjustment for ever/never use of the three pesticides mostly highly correlated with the pesticide of interest to account for co-exposures (rho range = 0.001--0.2). We also explored adjustment of all models with pesticides previously linked to aggressive PCa in the AHS (malathion, fonofos, terbufos, and aldrin) \[[@CR12]\] as well as with those significantly associated with PCa in the current analysis (Supplemental Table [3](#MOESM3){ref-type="media"}). However, adjustment for co-exposures did not materially impact observed point estimates and were not retained in models. We conducted exposure-response analyses for those pesticides with valid reported duration data from the Phase 3 questionnaire. We created categories for years of use based on the distribution of years reported, split at the median, among all cases. Those with reported years of use that were implausible were coded as having missing exposure in duration analyses. To compute tests for linear trend, the Wald test was used, treating the median value for each category as continuous. We evaluated potential effect modification by family history of PCa. Likelihood ratio tests were used to assess differences between strata.

Using multivariate logistic regression, we also explored possible predictors of prostate specific antigen (PSA) screening including demographic characteristics and individual pesticide use to assess whether screening could explain any observed relationships between pesticides and prostate cancer risk. Participants provided PSA screening (yes/no) information on two follow-up questionnaires (*N* = 28,880 men).

All analyses were conducted using SAS, 9.4 (SAS Institute, Cary, North Carolina) and use AHS data release P1REL201701, P2REL201701, and P3REL201701.

Results {#Sec7}
=======

Of the pesticides evaluated in this analysis, acetochlor (10.8%) and picloram (10.6%) were the most commonly reported herbicides and cyfluthrin was the most commonly reported insecticide (7.6%) (Table [1](#Tab1){ref-type="table"}). For all pesticides, most applicators reported years of use that were within the plausible range of years of market availability (average percent of applicators reporting plausible years was 97.7% \[range: 88.5--100%\]). Several pesticides were first registered for use at or after the initial enrollment in the AHS (*n* = 7 on or after 1993) and many others (*n* = 14) within 10-years prior to enrollment. Table 1U.S. registration year and accuracy of self-reported pesticide duration history for 38 chemicals reported on the AHS Phase 3 follow-up questionnaire (*n* = 24,170)Common nameClassPhase 1\
Take-home questionnaire^a^Date first registered in U.S.^b^Applicators reported pesticide useUsers with plausible responses^c^n%n%**Herbicide** AcetochlorAmide1981--1994260410.8255798.2 AcifluorfenDiphenyl ether●19803211.331798.8 BromoxynilNitrile●19656792.867899.9 ClethodimCyclohexene oxime19925452.352396.0 ClomazoneOxazole●19853161.330797.2 ClopyralidPyridine/Aromatic acid198712625.2125299.2 Cloransulam-methylTriazolopyrimidine/Amide19975862.455494.5 DimethenamidAmide19917483.172596.9 Fenoxaprop-p-ethylPhenoxy19855512.354899.5 Fluazifop-butylPhenoxy●19836462.763898.8 FlumetsulamAmide/Triazolopyrimidine198510954.5108799.3 FomesafenAmide/Diphenyl ether19876602.765699.4 Glufosinate-ammoniumOrganophosphorous199317267.1168597.6 ImazaquinImidazolinone●1986960.49497.9 IsoxaflutoleOxazole/Cyclopropylisoxazole19989754.090292.5 LinuronUrea●1966480.248100.0 Maleic hydrazideGrowth inhibitor/ Gametocides19523871.638699.7 MesotrioneBenzoylcyclohexanedione200122439.3198588.5 NicosulfuronUrea199016937.0166898.5 PicloramAromatic acid/ Pyridine1964256310.6255899.8 RimsulfuronUrea199411464.7111797.5 SethoxydimCyclohexene oxime●19824381.842997.9 SimazineTriazine●19573531.5353100.0 Sodium bentazonUnclassified●1974/1975--19853821.6382100.0 Thifensulfuron-methylUrea●19893881.636995.1 TriclopyrPyridine197914406.0141698.3**Insecticide** AcephateOrganophosphorous●197411975.0114595.7 Bacillus thuringiensisUnclassified●19612000.819899.0 ChloropicrinUnclassified●19752391.022393.3 CyfluthrinPyrethroid198718497.6180597.6 DisulfotonOrganophosphorous●19612701.126999.6 DimethoateOrganophosphorous●19621920.8192100.0 EndosulfanOrganochlorine●19542030.8203100.0 Lambda-cyhalothrinPyrethroid19898763.686799.0 MethomylCarbamate●19681620.716098.8 TebupirimfosOrganophosphorous1990--199511985.0114895.8 TefluthrinPyrethroid●19897673.273395.6**Nematicide** 1, 3-dichloropropeneFumigant●19541580.7158100.0^a^Filled circle means chemical first appeared on take-home questionnaire; no circle means chemical first appeared on follow-up questionnaires (Phase 2/3)^b^Range of years presented for pesticides with evidence of use prior to established registration year; for duration of market availability calculations, the lower bound of years was used (for those with a range) and rounding to a 5- or 10-year increment was calculated occurred if it fell 1 year short of this increment^c^Plausible responses were those where total years reported were ≤ number of years calculated between Phase 3 completion year (2005--2010) and the official pesticide registration date

The distribution of major prostate cancer risk factors was similar in the two analytic populations in the current analysis as well as compared to the full cohort of private applicators (Supplemental Table [4](#MOESM4){ref-type="media"}). The total number of PCa cases was 3169, with aggressive cases making up 54.6% of all cases.

For pesticides first reported on the take-home questionnaire, there was a significantly increased risk of aggressive PCa among ever users of dimethoate (HR =1.37, 95% CI = 1.04, 1.80) compared to never users (Table [2](#Tab2){ref-type="table"}). When we included additional exposure information reported in follow-up questionnaires, the risk for dimethoate was similar (HR =1.29, 95% CI = 0.98, 1.70). The increased risk for dimethoate was unchanged with additional adjustment for highly correlated pesticides or with any other pesticides linked to PCa (data not shown). The association between dimethoate use and aggressive PCa appeared stronger in those with a positive family history of PCa (HR = 1.84, 95% CI = 0.99, 3.43) compared to those without a family history of PCa (HR = 1.31, 95% CI = 0.96, 1.79), but the interaction was not statistically significant (P~interaction~ = 0.32; data not shown). We observed slightly elevated HRs between ever use of bromoxynil (HR =1.17, 95% CI = 0.99, 1.37), linuron (HR =1.19, 95% CI = 0.99, 1.42), and sethoxydim (HR =1.12, 95% CI = 0.96, 1.30) and aggressive PCa, but none were statistically significant (Table [2](#Tab2){ref-type="table"}). We did not observe any statistically significant interactions between any specific pesticide use reported on the take-home questionnaire and family history of prostate cancer. Table 2Association between pesticide (ever/never use) and aggressive PCa for those pesticides first reported at the Phase 1 take-home (TH) questionnaire in the Agricultural Health Study (AHS)Common namePhase 1 take-home questionnaire only\
(*n* = 20,923)Phase 1 take-home questionnaire including follow-up (Phase 2/Phase 3 questionnaire) exposure information^b^Non-caseAggressive PCaHR^a^ (95% CI)Non-caseAggressive PCaHR^a^ (95% CI)**Herbicide** Acifluorfen  Never use16,626744113,3716211  Ever use34141391.08 (0.90, 1.30)36421461.06 (0.89, 1.27) Bromoxynil  Never use14,609628111,5575231  Ever use54312551.17 (0.99, 1.37)57582661.14 (0.96, 1.34) Clomazone  Never use16,850756113,4716321  Ever use31901270.96 (0.79, 1.17)34621320.94 (0.78, 1.14) Fluazifop-butyl  Never use16,682750113,0776201  Ever use33581331.07 (0.89, 1.29)39091491.01 (0.84, 1.21) Imazaquin  Never use17,052770113,8806461  Ever use29881130.99 (0.81, 1.20)31011160.99 (0.81, 1.20) Linuron  Never use17,509742114,2676221  Ever use25311411.19 (0.99, 1.42)25481431.19 (0.996, 1.43) Sethoxydim  Never use14,404647111,4865461  Ever use56362361.12 (0.96, 1.30)58352391.07 (0.91, 1.24) Simazine  Never use18,454803114,9226711  Ever use1586801.19 (0.94, 1.51)1724861.17 (0.93, 1.48) Sodium bentazon  Never use12,911573110,2504761  Ever use71293101.08 (0.93, 1.25)73323171.06 (0.91, 1.23) Thifensulfuron-methyl  Never use18,108821114,3556681  Ever use1932620.91 (0.70, 1.18)2389831.00 (0.79, 1.26)**Insecticide** Acephate  Never use18,069811114,3776711  Ever use1971721.06 (0.82, 1.39)2427851.00 (0.77, 1.29) Bacillus thuringiensis  Never use18,256813114,8556891  Ever use1784701.00 (0.77, 1.29)1904710.93 (0.72, 1.20) Chloropicrin  Never use19,644865115,9447301  Ever use396181.48 (0.92, 2.38)566201.21 (0.77, 1.91) Disulfoton  Never use18,332815114,9276841  Ever use1708680.96 (0.74, 1.26)1807720.96 (0.74, 1.25) Dimethoate  Never use19,262829115,6736951  Ever use77854**1.37 (1.04, 1.80)**870551.29 (0.98, 1.70) Endosulfan  Never use19,407860115,7777221  Ever use633230.85 (0.56, 1.30)750250.78 (0.51, 1.17) Methomyl  Never use18,532827115,1336981  Ever use1508561.05 (0.78, 1.40)1597581.03 (0.77, 1.37) Tefluthrin  Never use18,635828114,8056841  Ever use1405550.99 (0.75, 1.31)1855710.98 (0.76, 1.25)**Nematicide** 1, 3-dichloropropene  Never use19,172848115,6697161  Ever use868351.14 (0.80, 1.62)944371.11 (0.78, 1.57)**Other** Arsenical pesticides^c^  Never use19,3098281------  Ever use731551.17 (0.88, 1.55)------^a^Using age as the time metric and adjusted for state, birth year, family history of PCa, race, and smoking status^b^Numbers add to less than total number of take-home responders (*n* = 20,923) due to missing responses for follow-up use information^c^Arsenical pesticides consist of lead arsenate (insecticide), organic arsenic (herbicide), and inorganic arsenic (herbicide); only reported use reported on take-home questionnaire

For pesticides first reported at Phase 2 and/or Phase 3 follow-ups, there was a significant inverse association between ever use of triclopyr and aggressive PCa (HR =0.68, 95% CI = 0.48, 0.95) (Table [3](#Tab3){ref-type="table"}). The risk was not impacted by additional adjustment for other highly correlated pesticides or with any other pesticide linked to PCa (data not shown). Exposure-response analyses evaluating years of use of triclopyr showed that the HR was lowest among those who reported using triclopyr ≥ 4 years compared to never users (HR =0.44, 95% CI = 0.26, 0.77, *n* = 13 exposed cases, *p*-value for trend = 0.004, Table [4](#Tab4){ref-type="table"}). We observed no other positive or inverse associations between ever use or duration of use of other pesticides first reported at follow-up and aggressive PCa (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). Table 3Association between pesticide (ever/never use) and aggressive PCa for those pesticides first reported at follow-up (Phase 2 and Phase 3 questionnaires) in the Agricultural Health Study (AHS)Common nameFollow-up questionnaire (Phase 2 and Phase 3)^b^\
*N* = 18,933Non-caseAggressive PCaHR^a^ (95% CI)**Herbicide** Acetochlor  Never use15,1106401  Ever use3089940.87 (0.70, 1.09) Clethodim  Never use17,5267171  Ever use673171.03 (0.64, 1.68) Clopyralid  Never use16,5136901  Ever use1686440.79 (0.58, 1.08) Cloransulam-methyl  Never use17,4537091  Ever use746251.13 (0.76, 1.69) Dimethenamid  Never use17,2387091  Ever use961250.82 (0.55, 1.23) Fenoxaprop-p-ethyl  Never use17,2287031  Ever use971311.00 (0.69, 1.44) Flumetsulam  Never use16,6126871  Ever use1587470.91 (0.67, 1.23) Fomesafen  Never use16,9556901  Ever use1244441.08 (0.80, 1.48) Glufosinate-ammonium  Never use16,5386921  Ever use1661420.81 (0.59, 1.11) Isoxaflutole  Never use17,1727031  Ever use1027311.03 (0.72, 1.49) Maleic hydrazide  Never use17,3267091  Ever use873250.91 (0.60, 1.38) Mesotrione  Never use16,3126921  Ever use1887420.80 (0.58, 1.10) Nicosulfuron  Never use15,9316741  Ever use2268600.78 (0.60, 1.03) Picloram  Never use15,8486521  Ever use2351820.97 (0.77, 1.23) Rimsulfuron  Never use16,7286941  Ever use1471400.83 (0.60, 1.15) Triclopyr  Never use16,7886991  Ever use141135**0.68 (0.48, 0.95)Insecticide** Cyfluthrin  Never use16,3996911  Ever use1800430.81 (0.59, 1.10) Lambda-cyhalothrin  Never use17,2577121  Ever use942220.96 (0.63, 1.47) Tebupirimfos  Never use17,0367021  Ever use1163320.86 (0.60, 1.23)^a^Using age as the time metric and adjusted for state, birth year, family history of PCa, race, and smoking status^b^Numbers may not add up to total, due to missing responses for pesticidesTable 4Association between duration of pesticide use (in years) and aggressive PCa for those pesticides first reported at follow-up (Phase 2 and Phase 3 questionnaires) in the Agricultural Health Study (AHS)^b^Common nameNon-caseAggressive PCaHR (95% CI)^a^**Herbicide** Acetochlor  Never use15,0976331  \< 9 years1213280.76 (0.52, 1.12)  ≥ 9 years882301.12 (0.77, 1.63)  p-trend0.96 Clopyralid  Never use16,5046841  \< 5 years46990.66 (0.34, 1.28)  ≥ 5 years565150.88 (0.53, 1.47)  p-trend0.39 Glufosinate-ammonium  Never use16,5166831  \< 5 years613120.67 (0.38, 1.20)  ≥ 5 years526161.03 (0.62, 1.70)  p-trend0.79 Mesotrione  Never use16,2846801  \< 4 years753170.82 (0.50, 1.33)  ≥ 4 years856170.77 (0.48, 1.26)  p-trend0.22 Nicosulfuron  Never use15,9216681  \< 5 years560150.88 (0.53, 1.48)  ≥ 5 years820210.84 (0.54, 1.30)  p-trend0.39 Picloram  Never use15,8176371  \< 6 years899321.15 (0.80, 1.65)  ≥ 6 years1145320.79 (0.55, 1.14)  p-trend0.28 Rimsulfuron  Never use16,7176901  \< 4 years333101.00 (0.54, 1.88)  ≥ 4 years573140.78 (0.46, 1.32)  p-trend0.39 Triclopyr  Never use16,7706901  \< 4 years282100.99 (0.53, 1.85)  ≥ 4 years84813**0.44 (0.26, 0.77)**  p-trend**0.004Insecticide** Cyfluthrin  Never use16,3806861  \< 6 years803170.71 (0.44, 1.15)  ≥ 6 years645140.82 (0.48, 1.39)  p-trend0.22 Tebupirimfos  Never use17,0226981  \< 6 years540120.69 (0.39, 1.23)  ≥ 6 years381121.09 (0.61, 1.93)  p-trend0.67^a^Using age as the time metric and adjusted for state, birth year, family history of PCa, race, and smoking status^b^Numbers add to less than total number of follow-up responders (*n* = 18,933) due to missing responses for duration of use information

Supplemental Table [5](#MOESM5){ref-type="media"} shows various predictors of PSA screening. Eighty-one percent of all men (23,416/28,880) and 87% of men over the age of 50 (22,217/25,421) had received a PSA test (Supplemental Table [5](#MOESM5){ref-type="media"}). Nearly all PCa cases were screened for PSA (overall PCa: 92.6%, aggressive PCa: 91.7%;). State, family history, age, marriage status, smoking status, educational attainment, and BMI were all predictors of PSA. Neither dimethoate nor triclopyr were associated with PSA testing, after controlling for other predictors.

Discussion {#Sec8}
==========

This study reports on the risk of aggressive PCa in relation to use of 39 individual pesticides that have not been previously evaluated in a large prospective cohort of private pesticide applicators. We found no association between the use of most of these pesticides and risk of aggressive prostate cancer. However, we did find a significantly elevated risk of aggressive PCa among ever users of the OP insecticide dimethoate and an inverse association between ever use of the herbicide triclopyr. We also found suggestive associations with commonly used herbicides such as bromoxynil, linuron, and sethoxydim and aggressive PCa.

Dimethoate (O,O-dimethyl S-methylcarbamoylmethyl phosphorodithioate) is a dithioate OP insecticide. It was first registered for use in the U.S. in 1962 for use on alfalfa, wheat, cotton, and corn \[[@CR25]\]. In 1983, the International Agency for Research on Cancer (IARC) failed to classify dimethoate regarding human carcinogenicity due to lack of available data \[[@CR26]\]. In 1991, the U.S. EPA classified dimethoate as a possible human carcinogen (Group C). Dimethoate exhibited carcinogenic effects in some strains of rats and mice, with neoplasms occurring in the endocrine organs, liver, and lymphatic systems \[[@CR27]\]; however, there have been no links to prostate cancer in humans. In this analysis, we observed a higher risk for aggressive PCa among applicators who reported dimethoate use. Pesticide applicators who reported use of dimethoate were more likely to report application methods related to animals, which is also consistent with known uses for dimethoate \[[@CR28]\]. Our inclusion of information on pesticide use during follow-up yielded a similar magnitude of elevated risk, although the association was no longer statistically significant. This may be due to a decrease in sample size from non-response in the follow-up questionnaires. Exposure-response analyses for duration of dimethoate use were also precluded due to a lack of use during follow-up for this insecticide (primarily historical use). Work practice information from pesticide applicators who used dimethoate suggested that variations in application methods and use of personal protective equipment did not materially change the observed association between dimethoate and aggressive prostate cancer (data not shown).

To our knowledge, no previous epidemiologic studies have reported on the specific relationship between dimethoate and PCa (or any other cancer site); however, some studies found associations between aggressive PCa risk and exposure to other dithioate insecticides, including fonofos, malathion, terbufos, and azinphos-methyl \[[@CR12], [@CR29]\]. The mechanism of pesticidal action of OP insecticides is to inhibit the enzyme that breaks down the neurotransmitter acetylcholine; however, this mechanism has not been explicitly linked to prostate cancer risk. Recently, a large genomic analysis of prostate cancer in 140,000 men found that genetic variants in pathways related to neurotransmission release were enriched in prostate cancer \[[@CR30]\]. We also have suggested that pesticides may interact with genetic variants in signal transduction and cellular communication pathways affected by neurotransmission \[[@CR31]\]. Thus, a link between acetylcholinesterase inhibition and prostate cancer is plausible. These findings indicate the need for future work on OP insecticides (specifically organodithioate insecticides) to identify a biologically plausible link to prostate cancer.

We also found an inverse association between triclopyr use and aggressive PCa. Exposure-response analyses, using lifetime years of use among those who completed the Phase 3 questionnaire showed that increasing years of use was significantly associated with a decreased risk of prostate cancer (p-trend = 0.008). In 1995, the U.S. EPA deemed triclopyr not classifiable as to human carcinogenicity (Group D) because no epidemiologic studies had been conducted and only suggestive results had been seen in animal studies \[[@CR32]\]. Triclopyr (3,5,6-trichloro-2-pyridyloxyacetic acid) is a pyridine herbicide, which breaks down into 3,5,6-trichloro-2-pyridinol (TCPy) in the soil. Studies have suggested that TCPy can persist for a maximum of 9 months, but most soil samples exhibited a half-life of less than 90 days \[[@CR33]\]. There have been some epidemiologic studies evaluating the association between the TCPy---also a metabolite of the insecticide chlorpyrifos---and sex and thyroid hormones \[[@CR34]--[@CR36]\]. These studies observed decreased levels of testosterone \[[@CR34]\], estradiol \[[@CR33]\], and altered levels of thyroid function markers, several of which have been suspected in the etiology of prostate cancer \[[@CR37]--[@CR43]\]. However, in humans, triclopyr is rapidly eliminated with more than 80% unchanged when excreted in urine, thus, it is unclear if there would be hormonal effects in humans from TCPy exposure \[[@CR44]\]. There are no direct data about possible endocrine disrupting properties of triclopyr and alternative explanations including the possibility of a chance finding cannot be ruled out. This pesticide, however, is commonly mixed with suspected endocrine disrupting chlorophenoxy herbicides \[[@CR45], [@CR46]\] because of a common mechanism of action (triclopyr is the pyridine analogue of 2,4,5- trichlorophenoxyacetic acid).

There were small increased risks of aggressive PCa from reported use of the herbicides bromoxynil, linuron, and sethoxydim, but none were statistically significant. Bromoxynil, or bromoxynil phenol, was classified by the U.S. EPA as a possible human carcinogen (Group C) in 1998 based on only a few studies conducted in animals \[[@CR47]\]. To our knowledge, there have been no human studies published on the health effects of bromoxynil. Linuron, or 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea, was classified by the U.S. EPA as a possible human carcinogen (Group C) in 1990 due to observed testicular effects in rats, including interstitial cell hyperplasia and adenomas \[[@CR48]\]. In rats, linuron is considered to play a toxic role in the male reproductive system as it has been indicated to significantly alter the expression of genes associated with testosterone synthesis, cell proliferation, and apoptosis \[[@CR49]\]. Sethoxydim, or 2\[1-(ethoxyimino)butyl\]-5-\[2-(ethylthio)propyl\]-3-hydroxy-2-cyclohexen-1-one, was classified by the U.S. EPA in 2005 as not likely to be carcinogenic in humans based on the lack of evidence of carcinogenicity in rats and mice \[[@CR50]\]. More data in humans are needed to adequately understand the relationship between exposure to these chemicals and cancer risk.

A strength of our study is the large size and the detailed information on pesticide use that allows for an assessment of individual pesticides in relation to the development of aggressive PCa. Pesticide applicators can reliably report on their use of pesticides \[[@CR51], [@CR52]\]. We found the reported duration of pesticide use by applicators showed a high level of agreement with the duration of plausible market availability across all pesticides. In addition, we focused our analyses to clinically relevant subtypes of PCa to identify risk factors for this more aggressive subtype of disease. When we evaluated the possible influence of PSA screening on risk estimates, we found that use of individual pesticides associated with risk was not related to a history of PSA screening (eliminating potential biases due to screening).

There were also limitations. The ability to evaluate cumulative lifetime use for some pesticides first reported in Phase 2 and Phase 3 is limited which may result in non-differential exposure misclassification. However, this exposure misclassification would likely result in biasing our results toward the null \[[@CR53]\]. Moreover, this is not an issue for the pesticides reported in Table [2](#Tab2){ref-type="table"}, where lifetime use before enrollment was assessed. We were also not able to conduct exposure-response analyses for all users of a given pesticide because lifetime duration of use information was only ascertained during the Phase 3 questionnaire. And in some instances, duration of use for pesticides that were reported had small numbers for adequately powered exposure-response analysis. For many of the pesticides reported in Table [3](#Tab3){ref-type="table"}, registration dates are relatively close to the time of prostate cancer diagnosis (approximately 5--15 years). Although there are limited data on the latent period for prostate cancer, it is possible that insufficient time has lapsed between exposure and cancer development for many of the pesticides evaluated here. In fact, thus far, positive associations for prostate cancer have only been observed for insecticides that were first registered for use primarily in the 1940s--1960s, suggesting a long latent period for pesticide-induced prostate cancer. Finally, we also made several comparisons, increasing the likelihood of a chance finding.

Conclusion {#Sec9}
==========

We found a significantly elevated risk of aggressive PCa among ever users of the OP insecticide dimethoate and an inverse association between ever use of the herbicide triclopyr. The association we observed between dimethoate and aggressive PCa adds another dithioate insecticide to the list of OPs associated with PCa risk in the AHS. Few other pesticides were associated with aggressive PCa, but extended follow-up of the cohort is warranted for this long latency cancer.
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**Additional file 1: Table S1.** Association between pesticide (ever/never use) and overall PCa for those pesticides first reported at the Phase 1 take-home (TH) questionnaire in the Agricultural Health Study (AHS). **Additional file 2: Table S2.** Association between pesticide (ever/never use) and overall PCa for those pesticides first reported at follow-up (Phase 2 and Phase 3 questionnaires) in the Agricultural Health Study (AHS). **Additional file 3: Table S3.** Correlation analysis between take-home pesticides and organophosphates previously identified as associated with aggressive PCa in the AHS. **Additional file 4: Table S4.** Selected characteristics of participants in the Agricultural Health Study (AHS) cohort; aggressive prostate cancer (PCa) cases reported through 2014 in North Carolina and 2015 in Iowa^a^. **Additional file 5: Table S5.** Prostate specific antigen (PSA) frequencies by selected characteristics^a^.
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